WHO Grade I Meningiomas: Classification-tree for Prognostic Factors of Survival
Overview
Authors
Affiliations
World Health Organization (WHO) grade I meningiomas are intracranial extracerebral tumors, in which microsurgery as a stand-alone therapy provides high rates of disease control and low recurrence rates. Our aim was to identify prognostic factors of overall survival and time-to-retreat (OS; TTR) in a cohort of patients with surgically managed WHO grade I meningioma. Patients with WHO grade I meningiomas from a retrospectively (1990 to 2002) and prospectively managed (2003 to 2010) databank of Oslo University Hospital, Norway, were included. The mean follow-up was 9.2 ± 5.7 years, with a total of 11,414 patient-years. One thousand three hundred fifty-five patients were included. The mean age was 58 ± 13.2, mean Karnofsky Performance Status (KPS) 92.6 ± 26.1 and female-to-male ratio 2.5:1. The 1-year, 5-year, 10-year, 15-year, and 20-year probabilities were 0.98, 0.91, 0.87, 0.84, and 0.8 for TTR. Patient age (OR 0.92 [0.91, 0.94]), male sex (OR 0.59 [0.45, 0.76]), preoperative KPS ≥ 70 (OR 2.22 [1.59, 3.13]), skull base location (OR 0.77 [0.60, 1]), and the occurrence of a postoperative hematoma (OR 0.44 [0.26, 0.76]) were identified as independent prognostic factors of OS. Patient age (OR 1.02 [1.01, 1.03]) and skull base location (OR 0.30 [0.21, 0.45]) were independent predictors of decreased PFS. Using a recursive partitioning analysis, we suggest a classification tree for the prediction of 5-year PFS based on patient and tumor characteristics. The findings from this cohort of meningioma WHO I patients helps to identify patients at risk of recurrence and tailor the therapeutic management.
Jiang J, Yu J, Liu X, Deng K, Zhuang K, Lin F Front Oncol. 2023; 12:1100350.
PMID: 36741697 PMC: 9890055. DOI: 10.3389/fonc.2022.1100350.
Management of Recurrent Meningiomas: State of the Art and Perspectives.
Corniola M, Meling T Cancers (Basel). 2022; 14(16).
PMID: 36010988 PMC: 9406695. DOI: 10.3390/cancers14163995.
Why we need new classification models in meningioma management.
Corniola M Acta Neurochir (Wien). 2022; 164(5):1381-1383.
PMID: 35067786 DOI: 10.1007/s00701-022-05127-8.
Neuropsychological Outcomes after Surgery for Olfactory Groove Meningiomas.
Constanthin P, Gondar R, Fellrath J, Wyttenbach I, Tizi K, Weman L Cancers (Basel). 2021; 13(11).
PMID: 34063924 PMC: 8196649. DOI: 10.3390/cancers13112520.
Yu J, Chen F, Zhang H, Zhang H, Luo S, Huang G Technol Cancer Res Treat. 2020; 19:1533033820983287.
PMID: 33356976 PMC: 7768868. DOI: 10.1177/1533033820983287.